Clare Senko

Bundoora, VIC 3086, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia.

Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: November 11, 2025

Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report.

Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report.

Journal: Case reports in oncological medicine

Published: October 06, 2025

Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial.

Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 20, 2025

Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Journal: Molecular cancer therapeutics

Published: July 15, 2024

Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies.

Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies.

Journal: PET clinics

Published: January 17, 2024

[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.

[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.

Journal: BMJ open

Published: August 04, 2023

Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy.

Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy.

Journal: Cancers

Published: September 27, 2022

Lung cancer in non-smokers: a diagnosis of increasing importance.

Lung cancer in non-smokers: a diagnosis of increasing importance.

Journal: The Medical journal of Australia

Published: October 06, 2021

The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective.

The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective.

Journal: Asia-Pacific journal of clinical oncology

Published: August 01, 2021

Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.

Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.

Journal: Oncoimmunology

Published: April 23, 2021

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 16, 2020

Durvalumab induced sarcoid-like pulmonary lymphadenopathy.

Durvalumab induced sarcoid-like pulmonary lymphadenopathy.

Journal: Respirology case reports

Published: December 14, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026